# Zydus Pharmaceuticals (Usa) Inc.

Canonical: https://abierto.us/vendors/zydus-pharmaceuticals-usa-inc-qmfqcplj9f36

- UEI: QMFQCPLJ9F36
- CAGE: 6YA44
- Location: Pennington, NJ
- Awards in window: 2 (68 transactions), $0 obligated, January 19, 2024 to September 4, 2026

## Awarding agencies

- Department of Veterans Affairs: 2 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 2 awards

## Solicitations won

- Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors Sitagliptin (36E79723R0037), $113,797,620. https://abierto.us/opportunities/36e79723r0037

## Largest awards

- 36E79724D0021: $0, Nac Pharmaceuticals. New Award for DPP-4 Sitagliptin with Zydus Pharmaceuticals (Usa)inc. Period of Performance Is 5/18/2024 - 5/17/2025 with Four ONE-YEAR Option Periods.. https://www.usaspending.gov/award/CONT_IDV_36E79724D0021_3600/
- 36F79721D0223: $0, Nac Federal Supply Schedule. 42-2B: Product Addition. https://www.usaspending.gov/award/CONT_IDV_36F79721D0223_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/zydus-pharmaceuticals-usa-inc-qmfqcplj9f36.